GASTROINTESTINAL SYMPTOMS FROM SEMAGLUTIDE ARE COMMON IN REAL-WORLD CLINICAL PRACTICE, THOUGH MEDICATION DISCONTINUATION RATES ARE SIMILAR AMONG PATIENTS WITH OR WITHOUT PRIOR DIGESTIVE COMPLAINTS

被引:0
|
作者
Cornet, Nicole
Rogers, Lindsay
Magahis, Patrick T.
Sharaiha, Reem Z.
Yeung, Michele
Krisko, Tibor
Buckholz, Adam
Kumar, Sonal
Newberry, Carolyn
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mo1918
引用
收藏
页码:S939 / S939
页数:1
相关论文
共 26 条
  • [11] Impact of Changes in Patient-Reported Symptoms of Irritable Bowel Syndrome with Diarrhea on Health-Related Quality of Life Among Patients Identified in Real-World Clinical Practice
    Doshi, Jalpa
    Marcus, Steven
    Rosenberg, Jonathan
    Kosinski, Lawrence
    Abel, Jessica
    Burslem, Kate
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S232 - S233
  • [12] Treatment of Heart Failure in Real-World Clinical Practice: Findings From the REFLECT-HF Registry in Patients With NYHA Class II Symptoms and a Reduced Ejection Fraction
    Boehm, Michael
    Tschoepe, Carsten
    Wirtz, Jost Henner
    Lokies, Jan
    Turgonyi, Eva
    Bramlage, Peter
    Lins, Katharina
    Strunz, Anke M.
    Tebbe, Ulrich
    CLINICAL CARDIOLOGY, 2015, 38 (04) : 200 - 207
  • [13] FACTORS ASSOCIATED WITH IMPAIRED QUALITY OF LIFE AMONG ATRIAL FIBRILLATION PATIENTS IN REAL-WORLD CLINICAL PRACTICE: INSIGHTS FROM THE PROSPECTIVE SPRINT-AF REGISTRY
    Ha, Andrew C. T.
    Labos, Christopher
    Kajil, Mahesh
    Tsigoulis, Michelle
    Cox, Jafna
    Dorian, Paul
    Mancini, G. B. John
    Gladstone, David
    Lockwood, Evan
    Shuaib, Ashfaq
    Chan, William
    Singh, Narendra
    Gupta, Milan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 520 - 520
  • [14] Anti-Dementia Drugs and Co-Medication Among Patients with Alzheimer’s DiseaseInvestigating Real-World Drug Use in Clinical Practice Using the Swedish Dementia Quality Registry (SveDem)
    Seyed-Mohammad Fereshtehnejad
    Kristina Johnell
    Maria Eriksdotter
    Drugs & Aging, 2014, 31 : 215 - 224
  • [15] Factors Associated With Changes in Quality of Life Among Atrial Fibrillation Patients in Real-World Clinical Practice: Findings From the Prospective Canadian SPRINT-AF Registry
    Ha, Andrew C.
    Labos, Christopher
    Dorian, Paul
    Mancini, G. B. John
    Cox, Jafna L.
    Gladstone, David J.
    Lockwood, Evan E.
    Singh, Narendra
    Shuaib, Ashfaq
    Padarath, Michelle
    Gupta, Milan
    CIRCULATION, 2019, 140
  • [16] Anti-Dementia Drugs and Co-Medication Among Patients with Alzheimer's Disease Investigating Real-World Drug Use in Clinical Practice Using the Swedish Dementia Quality Registry (SveDem)
    Fereshtehnejad, Seyed-Mohammad
    Johnell, Kristina
    Eriksdotter, Maria
    DRUGS & AGING, 2014, 31 (03) : 215 - 224
  • [17] RETENTION RATES AND CLINICAL OUTCOMES IN COHORTS OF PATIENTS (BIOLOGIC NAIVE OR FAILED PRIOR BIOLOGICS) TREATED WITH INTRAVENOUS ABATACEPT IN A REAL-WORLD SETTING: 6-MONTH RESULTS FROM THE ACTION STUDY
    Alten, R.
    Nuesslein, H.
    Galeazzi, M.
    Lorenz, H. -M.
    Mariette, X.
    Cantagrel, A.
    Chartier, M.
    Poncet, C.
    Rauch, C.
    Le Bars, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1056 - 1057
  • [18] Real-world clinical burden of non-seizure symptoms among patients with dravet syndrome or Lennox- Gastaut syndrome in Europe: Results from a global multinational survey
    Berthoz, F. Truong
    Shah, D.
    Biedermann, P.
    Villanueva, V.
    Benitez, A.
    Gibson, G.
    de Courcy, J.
    Ross, E.
    Andrews, J. S.
    EPILEPSIA, 2024, 65 : 375 - 375
  • [19] Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors versus other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL study
    Kosiborod, Mikhail
    Birkeland, Kare I.
    Cavender, Matthew A.
    Fu, Alex Z.
    Wilding, John P.
    Khunti, Kamlesh
    Holl, Reinhard W.
    Norhammar, Anna
    Jorgensen, Marit E.
    Wittbrodt, Eric T.
    Thuresson, Marcus
    Bodegard, Johan
    Hammar, Niklas
    Fenici, Peter
    DIABETES OBESITY & METABOLISM, 2018, 20 (08): : 1983 - 1987
  • [20] WHAT FACTORS INFLUENCE THE CHOICE OF APIXABAN, RIVAROXABAN, OR DABIGATRAN FOR STROKE PREVENTION AMONG ATRIAL FIBRILLATION PATIENTS IN REAL-WORLD CLINICAL PRACTICE? INSIGHTS FROM THE PROSPECTIVE SPRINT-AF REGISTRY
    Ha, Andrew C. T.
    Labos, Christopher
    Kajil, Mahesh
    Tsigoulis, Michelle
    Cox, Jafna
    Mancini, G. B. John
    Dorian, Paul
    Gladstone, David
    Lockwood, Evan
    Shuaib, Ashfaq
    Chan, William
    Singh, Narendra
    Gupta, Milan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 521 - 521